Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06255496 · ClinicalTrials.gov registry record
QStat Cartridge in Obstetric Patients
A clinical trial of Post Partum Hemorrhage and Blood Loss Massive, sponsored by HemoSonics.
- Completed
- Registry status
- 296
- Enrollment target
- 6
- Study locations
NCT06255496 is a study of Post Partum Hemorrhage and Blood Loss Massive that has completed, run by HemoSonics. The registered enrollment target is 296 participants, below the 1,754-participant average among 7 other Post Partum Hemorrhage trials with a reported enrollment target (83% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT06255496, a study of Post Partum Hemorrhage and Blood Loss Massive, has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 296 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in pregnant women at risk of bleeding at delivery.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quantra Hemostasis Analyzer with the QStat Cartridge
Study Locations (6)
New York
- University of Rochester Medical Center - Rochester
Ohio
- Ohio State University Wexner Medical Center - Columbus
Oklahoma
- University of Oklahoma Medical Center - Oklahoma City
Pennsylvania
- Magee Womens Hospital - Pittsburgh
Texas
- Parkland Health - Dallas
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 296 participants |
| Start Date | 2024-05-09 |
| Est. Completion | 2025-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06255496
The ClinicalTrials.gov registry entry for NCT06255496 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 296 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,754-participant average among 7 other Post Partum Hemorrhage trials with a reported enrollment target (83% lower). The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Post Partum Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Quantra Hemostasis Analyzer with the QStat Cartridge is the first listed.
NCT06255496 reports 6 study locations spanning 6 distinct geographic areas - top geographies include New York, Ohio, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06255496 about?
NCT06255496 is a clinical study titled "QStat Cartridge in Obstetric Patients". This study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in pregnant women at risk of bleeding at delivery.
What is the current status of trial NCT06255496?
This trial is currently completed. The enrollment target is 296 participants. The study started on 2024-05-09. Estimated completion is 2025-10-30.
What conditions does trial NCT06255496 study?
This clinical trial studies the following conditions: Post Partum Hemorrhage, Blood Loss Massive.
What interventions are being tested in trial NCT06255496?
The interventions under investigation include: Quantra Hemostasis Analyzer with the QStat Cartridge (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06255496?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06255496 being conducted?
This trial has 6 study locations across New York, Ohio, Oklahoma, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Partum Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oxytocin Pharmacokinetics and Pharmacodynamics
RECRUITING · Phase 2
-
A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage
RECRUITING · NA
-
Prevention of Postpartum Hemorrhage With Tranexamic Acid
RECRUITING · Phase 2
-
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
RECRUITING
-
Hemoglobin Testing in Pregnant Patients
RECRUITING
-
Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.